Abstract:ObjectiveThis study aimed to investigate the immune response of a pregnant woman who recovered from the coronavirus disease 2019 (COVID_RS) by using single-cell transcriptomic profiling of peripheral blood mononuclear cells (PBMCs) and to analyze the properties of different immune cell subsets.MethodsPBMCs were collected from the COVID_RS patient at 28 weeks of gestation, before a cesarean section. The PBMCs were then analyzed using single-cell RNA sequencing. The transcriptional profiles of myeloid, T, and natural killer (NK) cell subsets were systematically analyzed and compared with those of healthy pregnant controls from a published single-cell RNA sequencing data set.ResultsWe identified major cell types such as T cells, B cells, NK cells, and myeloid cells in the PBMCs of our COVID_RS patient. The increase of myeloid and B cells and decrease of T cells and NK cells in the PBMCs in this patient were quite distinct compared with that in the control subjects. After reclustering and Augur analysis, we found that CD16 monocytes and mucosal-associated invariant T (MAIT) cells were mostly affected within different myeloid, T, and NK cell subtypes in our COVID_RS patient. The proportion of CD16 monocytes in the total myeloid population was increased, and the frequency of MAIT cells in the total T and NK cells was significantly decreased in the COVID-RS patient. We also observed significant enrichment of gene sets related to antigen processing and presentation, T-cell activation, T-cell differentiation, and tumor necrosis factor superfamily cytokine production in CD16 monocytes, and enrichment of gene sets related to antigen processing and presentation, response to type II interferon, and response to virus in MAIT cells.ConclusionOur study provides a single-cell resolution atlas of the immune gene expression patterns in PBMCs from a COVID_RS patient. Our findings suggest that CD16-positive monocytes and MAIT cells likely play crucial roles in the maternal immune response against severe acute respiratory syndrome coronavirus 2 infection. These results contribute to a better understanding of the maternal immune response to severe acute respiratory syndrome coronavirus 2 infection and may have implications for the development of effective treatments and preventive strategies for the coronavirus disease 2019 in pregnant women.

Umbilical cord blood-derived microglia-like cells to model COVID-19 exposure

Umbilical cord blood derived microglia-like cells to model COVID-19 exposure

A microglia-containing cerebral organoid model to study early life immune challenges

Maternal SARS-CoV-2 impacts fetal placental macrophage programs and placenta-derived microglial models of neurodevelopment

Neonatal immune cells have heightened responses following in-utero exposure to chorioamnionitis or COVID-19

Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation

Human Umbilical Cord-Mesenchymal Stem Cells Promote Extracellular Matrix Remodeling in Microglia

Fetal brain response to maternal inflammation requires microglia

Generating Neuroimmune Assembloids Using Human Induced Pluripotent Stem Cell (iPSC)-Derived Cortical Organoids and Microglia

Cellular and Molecular Atlas of Peripheral Blood Mononuclear Cells from a Pregnant Woman after Recovery from COVID-19

Intrauterine exposure to SARS-CoV-2 infection and early newborn brain development

At the crux of maternal immune activation: Viruses, microglia, microbes, and IL‐17A

Triggered - does maternal COVID-19 program an exaggerated immune response in neonates?

Microglia determine an immune-challenged environment and facilitate ibuprofen action in human retinal organoids

Emerging Models to Study Human Microglia In vitro

The Effects of Environmental Adversities on Human Neocortical Neurogenesis Modeled in Brain Organoids

The Outcomes of Maternal Immune Activation Induced with the Viral Mimetic Poly I:C on Microglia in Exposed Rodent Offspring

Mild/asymptomatic COVID-19 in unvaccinated pregnant mothers impairs neonatal immune responses

Human-Mouse Chimeric Brain Models to Study Human Glial-Neuronal and Macroglial-Microglial Interactions

Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection

iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases